Abstract | Background: Methods: Results: Conclusion: The antitumor effects of IM176 were comparable with those of other biguanides. IM176 may therefore be a novel candidate for the treatment of patients with prostate cancer, including those with CRPC.
|
Authors | Yunlim Kim, Sangjun Yoo, Bumjin Lim, Jun Hyuk Hong, Cheol Kwak, Dalsan You, Jung Jin Hwang, Choung-Soo Kim |
Journal | Prostate international
(Prostate Int)
Vol. 11
Issue 2
Pg. 83-90
(Jun 2023)
ISSN: 2287-8882 [Print] Korea (South) |
PMID | 37409095
(Publication Type: Journal Article)
|
Copyright | © 2023 The Asian Pacific Prostate Society. Published by Elsevier B.V. |